Skip to main content
. 2021 Nov 18;13(11):1951. doi: 10.3390/pharmaceutics13111951
PDT photodynamic therapy
PTT photothermal therapy
HT hyperthermia therapy
MT magnetic hyperthermia therapy
MNPs magnetic nanoparticles
AMF alternating magnetic field
ROS reactive oxygen
ICD immunogenic cell death
PFC perfluorocarbon
CS chitosan
NPs nanoparticles
OVA ovalbumin
DOX doxorubicin
PS photosensitisers
PoP Porphyrin-phospholipid
Qu quercetin
Pt platinum
CRT calreticulin
DAMPs damage-associated molecular patterns
TLR toll-like receptor
APC antigen-presenting cell
nMOF nano-metal organic framework
TME tumor microenvironment
PEG polyethylene glycol
PLGA poly(lactide-co-glycolic)
GO graphene oxide
PpIX protoporphyrin IX
PTX paclitaxel
SDT sonodynamic therapy
SPDT sono-photodynamic therapy
IgG immunoglobulin G
HIF1α hypoxia-inducible factor α
VEGF vascular growth factor
PCI photochemical Internalization
IDO1 indoleamine 2, 3-dioxygenase 1
CLTA-4 cytotoxic T-lymphocyte-associated antigen 4
PD-L1 programmed death-ligand 1
Ce6 chlorin e6
PEI polythylenimide
ERP enhanced permeability and retention effects
XPDT X-ray photodynamic therapy
LDL low-density lipoprotein
1MT dextro-1-methyltryptophan
LCP lipid-calcium-phosphate
EMT epithelial mesenchymal transition
HPD hematoporphyrin
MB methylene blue
NIR near infrared
ZnPc zinc phthalocyanine
ZnF16Pc zinc hexadecafluorophthalocyanine
ClAlPc aluminum chloride phthalocyanine
HYP hypericin
LAHP linoleic acid peroxide
CRT calreticulin
AXT axitinib
5-ALA 5-aminolevulinic acid
PAH polyacrylamide
PAA polyacrylic acid
H2TCPP tetrakis (4-carboxyphenyl) porphyrin
RNP ribonucleoprotein
EGFR epidermal growth factor receptor
HER-2 human epidermal growth factor receptor 2
TfR transferrin receptor
PIN photoimmune nanoconjugated platform